New Drug Approved for Protozoal Diarrhea in Children
Nitazoxanide (Alinia), from RomarkLaboratories, has been approvedby the FDA for the treatment ofchildren who have diarrhea causedby protozoa. This agent targetsCryptosporidium parvum andGiardia lamblia.
Treatment of ProtozoalDiarrhea in Children
Nitazoxanide (Alinia), from RomarkLaboratories, has been approvedby the FDA for the treatment ofchildren who have diarrhea causedby protozoa. This agent targetsCryptosporidium parvumandGiardia lamblia.
Nitazoxanide is available onlyin liquid form and should be takenwith food. There is no restriction onfood or beverage intake or activityduring treatment.
The most common side effectsare abdominal pain, diarrhea, vomiting,and headache.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
